| Home > Publications database > Ibrutinib in early stage CLL: Genetic risk factors and treatment outcome in the GCLLSG CLL12 trial. > Access to Fulltext |
| Restricted | |||||||
blood_bld-2025-032806-main
|
|||||||
| version 1 |
| ||||||